Growth Metrics

Alvotech (ALVO) Asset Writedowns and Impairment (2021 - 2025)

Alvotech filings provide 5 years of Asset Writedowns and Impairment readings, the most recent being -$8.7 million for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 150.16% to -$8.7 million in Q4 2025 year-over-year; TTM through Sep 2025 was $5.2 million, a 8.73% increase, with the full-year FY2023 number at $1.8 million, down 14.29% from a year prior.
  • Asset Writedowns and Impairment hit -$8.7 million in Q4 2025 for Alvotech, down from $3.5 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $10.6 million in Q2 2025 to a low of -$8.7 million in Q4 2025.
  • Median Asset Writedowns and Impairment over the past 5 years was $89000.0 (2021), compared with a mean of $343846.2.
  • Biggest five-year swings in Asset Writedowns and Impairment: surged 4473.02% in 2022 and later plummeted 150.16% in 2025.
  • Alvotech's Asset Writedowns and Impairment stood at -$63000.0 in 2021, then surged by 4473.02% to $2.8 million in 2022, then skyrocketed by 202.76% to $8.3 million in 2023, then plummeted by 141.76% to -$3.5 million in 2024, then plummeted by 150.16% to -$8.7 million in 2025.
  • The last three reported values for Asset Writedowns and Impairment were -$8.7 million (Q4 2025), $3.5 million (Q3 2025), and $10.6 million (Q2 2025) per Business Quant data.